相关实验视频

Updated: Sep 10, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

新辅助性PD-1阻塞:对于早期不匹配修复缺陷的固体瘤患者来说是一种新的治疗选择

Kristin G Anderson¹, Antoni Ribas²

¹Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA abv9kn@virginia.edu.

Journal for immunotherapy of cancer

|August 25, 2025

概括

DNA不匹配修复缺陷预测了PD-1阻断疗法的反应. 这种免疫疗法可以消除对完整反应的患者进行手术的需要,从而保持器官功能并减少副作用.

科学领域:

癌症学
免疫疗法
基因组学

背景情况:

在转移性癌症中,DNA不匹配修复缺陷 (dMMR) 是抗编程细胞死亡蛋白-1 (PD-1) 治疗反应的生物标志物.
在新辅助环境中PD-1阻断的有效性正在研究中.

研究的目的:

评估PD-1检查点阻塞在固体瘤新辅助剂环境中的有效性.
确定完整的临床反应是否可以避免手术的需要.

主要方法:

进行了2期临床研究.
患有固体恶性瘤的患者接受PD-1检查点阻塞治疗.

主要成果:

在新辅助的环境中,PD-1 阻断表现出潜力.
观察到完全的临床反应,表明非手术治疗的可能性.

结论:

新辅助的PD-1阻断显示为治疗固体瘤的前景.
器官的保存和手术副作用的减少是患者实现完整反应的潜在好处.

关键词:

生物标志物循环瘤DNA - ctDNA 大肠直肠癌免疫检查点抑制剂不匹配的修复 - MMR

更多相关视频

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.